Our goal is to rethink the offerings in the following categories:

  • Pulmonary drug delivery platforms/Inhaler devices
  • Non-medical respiratory congestion relief
  • Patient-to-Patient networking tools



We are committed to improving the lives of:

  • Chronically ill (Asthmatics, COPD, CF patients, Allergic Etc.)
  • Healthy consumers with temporary challenges (PM 2.5 pollution, indoor pollution, cough/cold etc.)



We join forces with major industry entities that are established in the markets that we aim for. We engage in partnerships at an early stage in order to tailor the product development to their specific market challenges. 

Together with established licensing partners, we aim to acquire a fair share of the global respiratory market.